Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02045823 · ClinicalTrials.gov registry record
OCT Agreement and Precision Study
A clinical trial, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 66
- Enrollment target
NCT02045823: Completed study, sponsored by Topcon Medical Systems.
NCT02045823 is a clinical trial that has completed, run by Topcon Medical Systems. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02045823 has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
To demonstrate clinical substantial equivalence of 3D OCT-1 Maestro as comparable to the commercially available iVue and NW-300. Also, to demonstrate clinical substantial equivalence of 3D OCT-2000 Maestro as comparable to the commercially available NW-300.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-03 |
What the finished NCT02045823 record still lists
NCT02045823 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02045823 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02045823 about?
NCT02045823 is a clinical study titled "OCT Agreement and Precision Study". To demonstrate clinical substantial equivalence of 3D OCT-1 Maestro as comparable to the commercially available iVue and NW-300. Also, to demonstrate clinical substantial equivalence of 3D OCT-2000 Maestro as comparable to the commercially available NW-300.
What is the current status of trial NCT02045823?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2014-01. Estimated completion is 2014-03.
Who is sponsoring clinical trial NCT02045823?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia